Improving the microbiome with prebiotics during cancer treatment- acute leukemia
- Conditions
- haematological canceracute leukemiaBlood - Haematological diseasesDiet and Nutrition - Other diet and nutrition disordersCancer - Leukaemia - Acute leukaemia
- Registration Number
- ACTRN12624000792527
- Lead Sponsor
- Metro North Hospital and Health Service
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 30
•age 18 years or older
•newly diagnosed acute leukemia or myelodysplasia undergoing high intensity
intravenous induction chemotherapy at the Royal Brisbane and Women’s Hospital
(RBWH)
•ability to provide written informed consent
•inflammatory bowel disease
•formal diagnosis of irritable bowel syndrome
•gastrointestinal resection
•ileostomy or colostomy
•any bariatric surgery including gastric bypass surgery, sleeve gastrectomy and gastric
band
•a contraindication to a high fibre diet (e.g. active diverticulitis or bowel obstruction)
•allergy/ intolerance to any ingredient in the fibre supplement
•current and planned ongoing consumption of probiotic or prebiotic supplement
•hepatitis B, hepatitis C or HIV infection unless viral load negative
•on carbamazepine
•inability to provide written informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method